The downregulation of morgana and the subsequent hyperactivation of ROCK has been found in 16% of patients with BCR-ABL positive CML and in 5 out of 5 patients with aCML [112]. Here, ABL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.